+Search query
-Structure paper
Title | Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia. |
---|---|
Journal, issue, pages | J. Med. Chem., Year 2024 |
Publish date | Jun 24, 2024 (structure data deposition date) |
Authors | Hudkins, R.L. / Allen, E. / Balcer, A. / Hoffman, I.D. / Iyer, S. / Neal, M. / Nelson, K.J. / Rideout, M. / Ye, Q. / Starrett, J.H. ...Hudkins, R.L. / Allen, E. / Balcer, A. / Hoffman, I.D. / Iyer, S. / Neal, M. / Nelson, K.J. / Rideout, M. / Ye, Q. / Starrett, J.H. / Patel, P. / Harris, T. / Swanson, R.V. / Bensen, D.C. |
External links | J. Med. Chem. / PubMed:39258897 |
Methods | X-ray diffraction |
Resolution | 2.53 - 2.939 Å |
Structure data | PDB-9cd5: PDB-9cd7: |
Chemicals | ChemComp-EDO: PDB-1av2: ChemComp-SO4: ChemComp-HOH: ChemComp-GOL: |
Source |
|
Keywords | TRANSFERASE/TRANSFERASE INHIBITOR / Kinase / Transferase / Inhibitor / Cancer / Achondroplasia / FGFR3 / FGFR / TRANSFERASE-TRANSFERASE INHIBITOR complex |